Twist Bioscience Announces Robust Antibody Discovery Services Integrating In Vivo, In Vitro And In Silico Approaches

Twist Bioscience Corporation has announced an integrated offering of antibody discovery services available to customers, combining Twist Biopharma’s synthetic libraries and AI machine learning with an in vivo immunization approach. This offering is able to provide customers with optimized, development-ready antibody candidates and will be led by Tracey Mullen, MBA, who was appointed senior vice president of biopharma for Twist Bioscience.